LGVN
Longeveron Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.81
+3.50%Aug 24, 2026, 20:05 UTC
Longeveron Inc. announced a 1-for-10 reverse split of its Class A and Class B common stock, previously approved by stockholders on July 1, 2026 and by the board on July 31, 2026.
Source:Aug 19, 2026, 00:00 UTC
Longeveron Inc. appointed Nirav S. Jhaveri as Chief Financial Officer, principal financial officer and principal accounting officer, effective August 17, 2026.
Aug 13, 2026, 06:47 UTC
Longeveron Inc. held its Q2 2026 earnings call on August 12, 2026, to discuss financial results and business updates.
Source:Jul 7, 2026, 05:57 UTC
Longeveron Inc. announced that CFO Lisa Locklear is stepping down and appointed Marie Washburn as Senior Vice President and CFO, effective July 13.
Source:Jun 5, 2026, 00:00 UTC
Lisa Locklear resigned as Chief Financial Officer of Longeveron Inc., effective July 10, 2026, and Marie Washburn was appointed as her successor.